Health
Diagnostic, therapeutic advance for rare neurodegenerative disorder – Medical Xpress
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type…
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
The inherited disease is linked to a mutation in the ATXN3 gene. This mutation, which affects the central nervous system, appears between the ages of 40 and 70, and is characterized by an unsteady gait, loss of muscle control,…
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General21 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News11 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General21 hours agoWhy the nation needs the Nationals to ditch Net Zero